起搏器治疗缓室率心衰治疗的疗效观察

Effect of Pacemaker in the Treatment of Bradycardia Heart Failure

目的:评价起搏器治疗缓室率心衰的可行性以及对患者心功能的影响。方法:选择本院2018年12月~2019年8月收治住院治疗的90例缓室率心衰患者,随机分为常规药物治疗的对照组(n=45)与起搏器治疗的观察组(n=45),比较患者治疗后心功能、6min步行距离变化情况以及不良事件发生情况。结果:治疗前,2组缓室率心衰患者心力衰竭分级NYHA、左室射血分数LVEF、心输出量CO以及6min步行距离对比治疗前改善,观察组改善更为明显,脑梗死、感染等不良事件发生风险少于对照组,P<0.05,有统计学意义。结论:起搏器治疗缓室率心衰可以促进患者心功能改善,延长患者6min步行距离,提高了患者的安全性,加速患者康复。

Objective:To evaluate the feasibility of pacemaker in the treatment of bradycardia heart failure and its effect on cardiac function.Methods:90 patients with bradycardia rate heart failure were randomly divided into two groups:the control group(n=45)treated with metoprolol and the observation group(n=45)treated with pacemaker,compare patients'heart function,changes in 6-min walking distance and occurrence of adverse events after treatment.Results:Before the treatment,NYHA,LVEF,CO and 6-min walking distance of heart failure were improved in two groups.The risk of adverse events such as cerebral infarction and infection was lower in the observation group than in the control group(P<0.05),which was statistically significant.Conclusion:Pacemaker treatment of bradycardia heart failure can promote the improvement of heart function,prolong the 6-minute walking distance of patients,improve the safety of patients,and accelerate the recovery of patients.